Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL was delisted on the 29th of September, 2022.
11 hedge funds and large institutions have $42.1M invested in Zealand Pharma A/S American Depositary Shares in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
17% less capital invested
Capital invested by funds: $50.5M → $42.1M (-$8.39M)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$532K |
| 2 |
AIC
AWM Investment Company
New York
|
+$118K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$24.5K |
| 4 |
Morgan Stanley
New York
|
+$11.2K |
| 5 |
JP Morgan Chase
New York
|
+$8.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$689K |
| 2 |
LCM
Laurion Capital Management
New York
|
-$250K |
| 3 |
Millennium Management
New York
|
-$171K |
| 4 |
Jane Street
New York
|
-$166K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$12K |
ZEAL Hedge Fund Activity: Q2 2018 in Review
11 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Zealand Pharma A/S American Depositary Shares (ZEAL) for Q2 2018, worth a combined $42.1M — down 17% from $50.5M a quarter earlier.
Fund positioning in ZEAL was balanced in Q2 2018: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 5 trimmed.
The largest buyer was Farallon Capital Management, adding an estimated $532K. The largest seller was Wellington Management Group, cutting an estimated $689K.
- 11 institutional investors held Zealand Pharma A/S American Depositary Shares (ZEAL) as of Q2 2018, unchanged from Q1 2018.
- Funds reported $42.1M of Zealand Pharma A/S American Depositary Shares stock for Q2 2018, down 17% quarter-over-quarter.
- 2 funds opened new Zealand Pharma A/S American Depositary Shares positions in Q2 2018 and 2 closed out, a net change of 0 holders.
- The largest Zealand Pharma A/S American Depositary Shares buyer in Q2 2018 was Farallon Capital Management, an estimated $532K added.
- The largest Zealand Pharma A/S American Depositary Shares seller in Q2 2018 was Wellington Management Group, an estimated $689K sold.
Based on aggregated 13F filings for Q2 2018.